Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 186

Alebund aligns with $60m

Lilly Asia Ventures was among the investors in a series B round for the renal disease treatment developer, which it incubated in 2018.

May 10, 2021

Corporates illuminate Lightmatter in $80m series B

Alphabet, Hewlett Packard Enterprise and Lockheed Martin invested in the photonic computing technology developer’s series B round, increasing its total funding to $113m.

May 10, 2021

Yikon Genomics picks up series D funding

The genome sequencing technology provider has boosted its total funding to approximately $124m, Sinopharm and China General Technology Group having backed a $38.7m round.

May 10, 2021

Valgen validates series B funding

China Life Healthcare Fund and Venus Medtech have taken part in a round for the heart valve treatment developer sized in the hundreds of millions of dollars.

May 7, 2021

Dyno Therapeutics evolves to raise $100m

GV was among the investors in a series A round led by Andreessen Horowitz closed three years after the gene therapy developer's launch.

May 7, 2021

Vast Data vaults to $83m series D

Nvidia participated in a round valuing the data storage technology provider, which counts Dell, Siemens and Mellanox as investors, at $3.7bn.

May 7, 2021

Florence finds $80m for series C round

The Atrium Health-backed clinical trial software provider increased its overall funding to over $88m in a round led by Insight Partners.

May 7, 2021

TwinStrand takes in $50m

Genetic sequencing platform developer TwinStrand has secured $50m in a series B round led by Section 32, while Alexandria Venture Investments invested for a third time.

May 7, 2021

Oculii locks up $55m

Hella and Susquehanna International Group both took part in a series B round that increased the radar technology developer's overall funding to $75m.

May 7, 2021
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here